The Association Between α1-Antitrypsin and Coronary Artery Ectasia

Fatma Nihan Turhan Caglar1, Vusal Ksanski1, Veli Polat1

  • 11 Cardiology Department, Bakirkoy Dr. Sadi Konuk Education and Research Hospital, Istanbul, Turkey.

Angiology
|March 9, 2016
PubMed

Insights

Lower serum alpha-1 antitrypsin (A1AT) levels are linked to coronary artery ectasia (CAE). This suggests A1AT deficiency may contribute to arterial wall weakening and ectasia formation in patients with this condition.

Area of Science:

  • Cardiology
  • Biochemistry
  • Genetics

Background:

  • Coronary artery ectasia (CAE) is a condition associated with coronary artery disease, but its pathophysiology remains unclear.
  • Alpha-1 antitrypsin (A1AT) is crucial in regulating protease activity, and A1AT deficiency (A1ATD) is linked to coronary artery disease.
  • Understanding factors contributing to CAE is vital for cardiovascular health management.

Purpose of the Study:

  • To investigate the association between serum A1AT levels and the presence of isolated CAE.
  • To determine if A1AT levels correlate with the extent of ectasia in patients with CAE.

Main Methods:

  • Serum A1AT levels were measured in 50 patients with isolated CAE and 46 controls using nephelometry.
  • Patients underwent coronary angiography, and CAE extent was assessed using the Markis score.
  • Statistical analysis compared A1AT levels between groups and correlated them with the Markis score.

Main Results:

  • Median A1AT levels were significantly lower in patients with isolated CAE compared to controls (P < .001).
  • No significant correlation was found between A1AT serum levels and the extent of CAE as determined by the Markis score (P = .41).

Conclusions:

  • Serum A1AT levels are inversely associated with the presence of coronary artery ectasia.
  • Reduced A1AT may compromise arterial wall integrity by impairing protease inhibition, potentially contributing to ectasia development.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
943
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
690
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
411
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
552
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
731